Cita APA

Nishiyama, H., Yamamoto, Y., Sassa, N., Nishimura, K., Fujimoto, K., Fukasawa, S., . . . Bellmunt Molins, J. (2020). Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: A subgroup analysis of the phase 3 KEYNOTE-045.

Citación estilo Chicago

Nishiyama, Hiroyuki, et al. Pembrolizumab Versus Chemotherapy in Recurrent, Advanced Urothelial Cancer in Japanese Patients: A Subgroup Analysis of the Phase 3 KEYNOTE-045. 2020.

Cita MLA

Nishiyama, Hiroyuki, et al. Pembrolizumab Versus Chemotherapy in Recurrent, Advanced Urothelial Cancer in Japanese Patients: A Subgroup Analysis of the Phase 3 KEYNOTE-045. 2020.